{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:33:01Z","timestamp":1793298781089,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Amyotrophic lateral sclerosis (ALS) remains a devastating motor neuron disease with limited treatment options. Oxaloacetate treatment has a neuroprotective effect in rodent models of seizure and neurodegeneration. Therefore, we treated the ALS model superoxide dismutase 1 (SOD1) <jats:sup>G93A<\/jats:sup> mice with oxaloacetate and evaluated their neuromuscular function and lifespan. Treatment with oxaloacetate beginning in the presymptomatic stage significantly improved neuromuscular strength measured during the symptomatic stage in the injected mice compared to the non-treated group. Oxaloacetate treatment starting in the symptomatic stage significantly delayed limb paralysis compared with the non-treated group. For lifespan analysis, oxaloacetate treatment did not show a statistically significant positive effect, but the treatment did not shorten the lifespan. Mechanistically, SOD1<jats:sup>G93A<\/jats:sup> mice showed increased levels of tumor necrosis factor-\u03b1 (TNF\u03b1) and peroxisome proliferative activated receptor gamma coactivator 1\u03b1 (PGC-1\u03b1) mRNAs in the spinal cord. However, oxaloacetate treatment reverted these abnormal levels to that of wild-type mice. Similarly, the altered expression level of total NF-\u03baB protein returned to that of wild-type mice with oxaloacetate treatment. These results suggest that the beneficial effects of oxaloacetate treatment in SOD1<jats:sup>G93A<\/jats:sup> mice may reflect the effects on neuroinflammation or bioenergetic stress.<\/jats:p>","DOI":"10.1038\/s41598-021-90438-6","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T10:04:00Z","timestamp":1622023440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Oxaloacetate treatment preserves motor function in SOD1G93A mice and normalizes select neuroinflammation-related parameters in the spinal cord"],"prefix":"10.1038","volume":"11","author":[{"given":"Sudheer K.","family":"Tungtur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yomna","family":"Badawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Sage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulbaki","family":"Agbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Jawdat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Barohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell H.","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nishimune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"90438_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fncel.2016.00044","volume":"10","author":"BM Edens","year":"2016","unstructured":"Edens, B. M., Miller, N. & Ma, Y. C. Impaired autophagy and defective mitochondrial function: converging paths on the road to motor neuron degeneration. Front. Cell Neurosci. 10, 44 (2016).","journal-title":"Front. Cell Neurosci."},{"key":"90438_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev.neuro.051508.135722","volume":"33","author":"KC Kanning","year":"2010","unstructured":"Kanning, K. C., Kaplan, A. & Henderson, C. E. Motor neuron diversity in development and disease. Ann. Rev. Neurosci. 33, 409\u2013440 (2010).","journal-title":"Ann. Rev. Neurosci."},{"key":"90438_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrneurol.2011.150","volume":"7","author":"PM Andersen","year":"2011","unstructured":"Andersen, P. M. & Al-Chalabi, A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know?. Nat. Rev. Neurol. 7, 603\u2013615 (2011).","journal-title":"Nat. Rev. Neurol."},{"key":"90438_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/mus.20489","volume":"33","author":"I Hervias","year":"2006","unstructured":"Hervias, I., Beal, M. F. & Manfredi, G. Mitochondrial dysfunction and amyotrophic lateral sclerosis. Muscle Nerve 33, 598\u2013608 (2006).","journal-title":"Muscle Nerve"},{"key":"90438_CR5","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772\u20131775 (1994).","journal-title":"Science"},{"key":"90438_CR6","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/0896-6273(95)90259-7","volume":"14","author":"PC Wong","year":"1995","unstructured":"Wong, P. C. et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105\u20131116 (1995).","journal-title":"Neuron"},{"key":"90438_CR7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1089\/ars.2007.1676","volume":"9","author":"RH Swerdlow","year":"2007","unstructured":"Swerdlow, R. H. Treating neurodegeneration by modifying mitochondria: potential solutions to a \u201ccomplex\u201d problem. Antioxid. Redox Signal. 9, 1591\u20131603 (2007).","journal-title":"Antioxid. Redox Signal."},{"issue":"Suppl 1","key":"90438_CR8","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/ana.21543","volume":"65","author":"JD Rothstein","year":"2009","unstructured":"Rothstein, J. D. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 65(Suppl 1), S3-9 (2009).","journal-title":"Ann. Neurol."},{"key":"90438_CR9","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1523\/JNEUROSCI.18-09-03241.1998","volume":"18","author":"J Kong","year":"1998","unstructured":"Kong, J. & Xu, Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18, 3241\u20133250 (1998).","journal-title":"J. Neurosci."},{"key":"90438_CR10","doi-asserted-by":"publisher","first-page":"21146","DOI":"10.1073\/pnas.1014862107","volume":"107","author":"Q Li","year":"2010","unstructured":"Li, Q. et al. ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc. Natl. Acad. Sci. 107, 21146\u201321151 (2010).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"90438_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3389\/fncel.2015.00341","volume":"9","author":"R Ruffoli","year":"2015","unstructured":"Ruffoli, R., Bartalucci, A., Frati, A. & Fornai, F. Ultrastructural studies of ALS mitochondria connect altered function and permeability with defects of mitophagy and mitochondriogenesis. Front. Cell Neurosci. 9, 341 (2015).","journal-title":"Front. Cell Neurosci."},{"key":"90438_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/00005072-198409000-00002","volume":"43","author":"A Hirano","year":"1984","unstructured":"Hirano, A. et al. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 43, 471\u2013480 (1984).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"90438_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00688069","volume":"38","author":"MN Hart","year":"1977","unstructured":"Hart, M. N., Cancilla, P. A., Frommes, S. & Hirano, A. Anterior horn cell degeneration and Bunina-type inclusions associated with dementia. Acta Neuropathol 38, 225\u2013228 (1977).","journal-title":"Acta Neuropathol"},{"key":"90438_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1001\/archneur.1987.00520130079022","volume":"44","author":"Y Nakano","year":"1987","unstructured":"Nakano, Y., Hirayama, K. & Terao, K. Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis. Arch. Neurol. 44, 103\u2013106 (1987).","journal-title":"Arch. Neurol."},{"key":"90438_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/14660820050515179","volume":"1","author":"RH Swerdlow","year":"2000","unstructured":"Swerdlow, R. H., Parks, J. K., Pattee, G. & Parker, W. D. Jr. Role of mitochondria in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor. Neuron. Disord. 1, 185\u2013190 (2000).","journal-title":"Amyotroph. Lateral Scler. Other Motor. Neuron. Disord."},{"key":"90438_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fnins.2017.00473","volume":"11","author":"RS Rogers","year":"2017","unstructured":"Rogers, R. S. et al. Impaired mitophagy plays a role in denervation of neuromuscular junctions in ALS mice. Front. Neurosci. 11, 473 (2017).","journal-title":"Front. Neurosci."},{"key":"90438_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1046\/j.0022-3042.2001.00731.x","volume":"80","author":"FR Wiedemann","year":"2002","unstructured":"Wiedemann, F. R., Manfredi, G., Mawrin, C., Beal, M. F. & Schon, E. A. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J. Neurochem. 80, 616\u2013625 (2002).","journal-title":"J. Neurochem."},{"key":"90438_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-510X(98)00008-2","volume":"156","author":"FR Wiedemann","year":"1998","unstructured":"Wiedemann, F. R. et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 156, 65\u201372 (1998).","journal-title":"J. Neurol. Sci."},{"issue":"Pt 7","key":"90438_CR19","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/brain\/123.7.1339","volume":"123","author":"S Vielhaber","year":"2000","unstructured":"Vielhaber, S. et al. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain 123(Pt 7), 1339\u20131348 (2000).","journal-title":"Brain"},{"key":"90438_CR20","first-page":"1","volume":"1","author":"F Bozzo","year":"2006","unstructured":"Bozzo, F., Mirra, A. & Carri, M. T. Oxidative stress and mitochondrial damage in the pathogenesis of ALS: New perspectives. Neurosci Lett 1, 1 (2006).","journal-title":"Neurosci Lett"},{"key":"90438_CR21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.ejmech.2016.02.048","volume":"121","author":"EC Browne","year":"2016","unstructured":"Browne, E. C. & Abbott, B. M. Recent progress towards an effective treatment of amyotrophic lateral sclerosis using the SOD1 mouse model in a preclinical setting. Eur. J. Med. Chem. 121, 918\u2013925 (2016).","journal-title":"Eur. J. Med. Chem."},{"key":"90438_CR22","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.2741\/4467","volume":"21","author":"R Rudolf","year":"2016","unstructured":"Rudolf, R., Khan, M. M., Wild, F. & Hashemolhosseini, S. The impact of autophagy on peripheral synapses in health and disease. Front. Biosci. 21, 1474\u20131487 (2016).","journal-title":"Front. Biosci."},{"key":"90438_CR23","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1093\/hmg\/ddu371","volume":"23","author":"HM Wilkins","year":"2014","unstructured":"Wilkins, H. M. et al. Oxaloacetate activates brain mitochondrial biogenesis, enhances the insulin pathway, reduces inflammation and stimulates neurogenesis. Hum. Mol. Genet. 23, 6528\u20136541 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"90438_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0378-4274(03)00114-0","volume":"143","author":"HA Yamamoto","year":"2003","unstructured":"Yamamoto, H. A. & Mohanan, P. V. Effect of alpha-ketoglutarate and oxaloacetate on brain mitochondrial DNA damage and seizures induced by kainic acid in mice. Toxicol. Lett. 143, 115\u2013122 (2003).","journal-title":"Toxicol. Lett."},{"key":"90438_CR25","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1474-9726.2009.00527.x","volume":"8","author":"DS Williams","year":"2009","unstructured":"Williams, D. S., Cash, A., Hamadani, L. & Diemer, T. Oxaloacetate supplementation increases lifespan in Caenorhabditis elegans through an AMPK\/FOXO-dependent pathway. Aging Cell 8, 765\u2013768 (2009).","journal-title":"Aging Cell"},{"key":"90438_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000382034","volume":"15","author":"A Ruban","year":"2015","unstructured":"Ruban, A. et al. Combined treatment of an amyotrophic lateral sclerosis rat model with recombinant GOT1 and oxaloacetic acid: a novel neuroprotective treatment. Neurodegener. Dis 15, 233\u2013242 (2015).","journal-title":"Neurodegener. Dis"},{"key":"90438_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/mus.20228","volume":"32","author":"CM Wooley","year":"2005","unstructured":"Wooley, C. M. et al. Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve 32, 43\u201350 (2005).","journal-title":"Muscle Nerve"},{"key":"90438_CR28","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuroscience.2009.08.031","volume":"164","author":"CR Hayworth","year":"2009","unstructured":"Hayworth, C. R. & Gonzalez-Lima, F. Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1(G93A) ALS mouse model. Neuroscience 164, 975\u2013985 (2009).","journal-title":"Neuroscience"},{"key":"90438_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1083\/jcb.200407021","volume":"168","author":"G Dobrowolny","year":"2005","unstructured":"Dobrowolny, G. et al. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J. Cell Biol. 168, 193\u2013199 (2005).","journal-title":"J. Cell Biol."},{"key":"90438_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2005.02.006","volume":"236","author":"TD Heiman-Patterson","year":"2005","unstructured":"Heiman-Patterson, T. D. et al. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J. Neurol. Sci. 236, 1\u20137 (2005).","journal-title":"J. Neurol. Sci."},{"key":"90438_CR31","unstructured":"Leitner, M., Menzies, S. & Lutz, C. Working with ALS mice, guidelines for preclinical testing & colony management. PRIZE4LIFE, The Jackson Laboratory, 1\u201328 (2009)."},{"key":"90438_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/17482960903545334","volume":"11","author":"AC Ludolph","year":"2010","unstructured":"Ludolph, A. C. et al. Guidelines for preclinical animal research in ALS\/MND: A consensus meeting. Amyotroph. Lateral Scler 11, 38\u201345 (2010).","journal-title":"Amyotroph. Lateral Scler"},{"key":"90438_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/17482960701856300","volume":"9","author":"S Scott","year":"2008","unstructured":"Scott, S. et al. Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph. Lateral Scler 9, 4\u201315 (2008).","journal-title":"Amyotroph. Lateral Scler"},{"key":"90438_CR34","doi-asserted-by":"crossref","unstructured":"Brohawn, D. G., O'Brien, L. C. & Bennett, J. P., Jr. RNAseq Analyses Identify Tumor Necrosis Factor-Mediated Inflammation as a Major Abnormality in ALS Spinal Cord. PLoS One 11, e0160520 (2016).","DOI":"10.1371\/journal.pone.0160520"},{"key":"90438_CR35","doi-asserted-by":"publisher","first-page":"11397","DOI":"10.1523\/JNEUROSCI.0602-06.2006","volume":"26","author":"G Gowing","year":"2006","unstructured":"Gowing, G., Dequen, F., Soucy, G. & Julien, J. P. Absence of tumor necrosis factor-alpha does not affect motor neuron disease caused by superoxide dismutase 1 mutations. J. Neurosci. 26, 11397\u201311402 (2006).","journal-title":"J. Neurosci."},{"key":"90438_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cytogfr.2014.02.001","volume":"25","author":"NH Ruddle","year":"2014","unstructured":"Ruddle, N. H. Lymphotoxin and TNF: how it all began-a tribute to the travelers. Cytokine Growth Factor Rev. 25, 83\u201389 (2014).","journal-title":"Cytokine Growth Factor Rev."},{"key":"90438_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbi.2017.03.003","volume":"64","author":"X Yang","year":"2017","unstructured":"Yang, X., Xu, S., Qian, Y. & Xiao, Q. Resveratrol regulates microglia M1\/M2 polarization via PGC-1alpha in conditions of neuroinflammatory injury. Brain Behav. Immun. 64, 162\u2013172 (2017).","journal-title":"Brain Behav. Immun."},{"key":"90438_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12868-017-0387-7","volume":"18","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. PPARgamma coactivator-1alpha (PGC-1alpha) protects neuroblastoma cells against amyloid-beta (Abeta) induced cell death and neuroinflammation via NF-kappaB pathway. BMC Neurosci. 18, 69 (2017).","journal-title":"BMC Neurosci."},{"key":"90438_CR39","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","volume":"81","author":"AE Frakes","year":"2014","unstructured":"Frakes, A. E. et al. Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis. Neuron 81, 1009\u20131023 (2014).","journal-title":"Neuron"},{"issue":"Suppl 1","key":"90438_CR40","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/S0022-510X(97)00247-5","volume":"152","author":"ME Gurney","year":"1997","unstructured":"Gurney, M. E. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. J. Neurol. Sci. 152(Suppl 1), S67-73 (1997).","journal-title":"J. Neurol. Sci."},{"key":"90438_CR41","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrneurol.2011.153","volume":"7","author":"O Hardiman","year":"2011","unstructured":"Hardiman, O., van den Berg, L. H. & Kiernan, M. C. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat. Rev. Neurol 7, 639\u2013649 (2011).","journal-title":"Nat. Rev. Neurol"},{"issue":"3","key":"90438_CR42","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/brain\/118.3.707","volume":"118","author":"LJ Haverkamp","year":"1995","unstructured":"Haverkamp, L. J., Appel, V. & Appel, S. H. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 118(3), 707\u2013719 (1995).","journal-title":"Brain"},{"key":"90438_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0166-4328(01)00231-5","volume":"124","author":"C Contet","year":"2001","unstructured":"Contet, C., Rawlins, J. N. & Deacon, R. M. A comparison of 129S2\/SvHsd and C57BL\/6JOlaHsd mice on a test battery assessing sensorimotor, affective and cognitive behaviours: implications for the study of genetically modified mice. Behav Brain Res 124, 33\u201346 (2001).","journal-title":"Behav Brain Res"},{"key":"90438_CR44","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/hmg\/ddh320","volume":"13","author":"J Cossins","year":"2004","unstructured":"Cossins, J. et al. A mouse model of AChR deficiency syndrome with a phenotype reflecting the human condition. Hum. Mol. Genet. 13, 2947\u20132957 (2004).","journal-title":"Hum. Mol. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90438-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90438-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90438-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T08:40:49Z","timestamp":1670056849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90438-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["90438"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-90438-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"assertion":[{"value":"18 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11051"}}